News
Dispensing Fees – The Roller Coaster Continues
October 2022 Hold tight, Dispensing Fees are now at their highest level ever. There has been a 47% INCREASE in Dispensing Fees from 1st October 2022 until 1 April 2023...
The November Gazette is ready to download!!
Christmas is Coming! This months’ highlights include: Hypromellose Update, Dispensing Fees-The Roller Coaster Continues, 3 Steps to Free Training, 2023 Tutorials, Ocular Lubricants 3 and much more! Upcoming Tutorials: November...
Winter Tutorials
We understand how busy your dispensary can be, but we also appreciate that everyone still needs to complete training for their DSQS requirements, therefore we are continuing to host our...
October 2022 Price Concessions- Final Update
Source: NHSBSA/ DHSC Drug Tariff News – October Part VIIIA reimbursement prices (issued 02 November) The Department of Health and Social Care has agreed the October Drug Tariff Part VIIIA...
How to improve your profitability
Cost of living Squeeze: How to improve your profitability With inflation reaching an eye-watering 10% the cost-of-living increase is really starting to impact practices. The highest outgoings in any practice...
Primary care offered genetic decision system
Source: Practice Index 25.10.22 GPs and their practice staff have been asked to evaluate a pioneering new resource aimed at helping them make decisions about patient genetic issues. Genomic notes...
MHRA Safety Survey
Consultation on how we communicate with healthcare professionals to improve medicines and medical devices safety. Source: MHRA The MHRA is reviewing its approach to engagement with healthcare professionals to improve...
Class 3 Medicines Recall: Medreich PLC, Mebeverine hydrochloride 135mg Film-coated tablets, EL (22)A/46
Source: MHRA / Gov.uk 27.10.22 Medreich PLC UK is recalling a batch of Mebeverine hydrochloride 135mg film-coated tablets as a precautionary measure due to out of specification results for tablet...
Class 4 Medicines Defect Information: Recordati Rare Diseases, Pedea 5 mg/ml solution for injection, EL(22)A/45
Source: MHRA/ Gov.uk 25.10.22 Recordati Rare Diseases T/A Recordati Rare Diseases UK Ltd has made the MHRA aware that specific batches of Pedea 5 mg/ml solution for injection have been...
NEW COURSE: Dispensing Review of Use of Medications (DRUMs)
NEW- Dispensing Review of Use of Medications (DRUMs) in a Dispensing Doctor setting Interested in completing one of our Bespoke Dispensing courses? This auto-marked programme will give you the knowledge...
Happy Diwali 2022
Happy Diwali to everyone that’s celebrating today!!
National Patient Safety Alert: Class 1 Medicines Recall Notification: Recall of Targocid 200mg powder for solution for injection/infusion or oral solution, Aventis Pharma Limited t/a Sanofi, due to the presence of bacterial endotoxins, NatPSA/2022/008/MHRA
Source MHRA / Gov.uk 21.10.22 Sanofi UK is initiating an urgent recall of two batches of Targocid 200mg powder for solution for injection/infusion or oral solution ational Patient Safety Alert...
